Lysine

Lysine

SCHEMBL124167

CC(=O)O.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.87
NOS2 P35228 5/20 0.56
NOS1 P29475 4/20 0.56
NOS3 P29474 3/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
TSHR P16473 1/20 0.56
BLM P54132 1/20 0.55
ARG2 P78540 4/20 0.53
ARG1 P05089 3/20 0.53
MEN1 O00255 1/20 0.53
CYP2C19 P33261 1/20 0.53
KMT2A Q03164 1/20 0.53
RNPEP Q9H4A4 1/20 0.52
CPB2 Q96IY4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL29126333 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL30642401 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL30642405 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL29397119 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL28422142 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL9070593 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL7131633 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL2400402 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL2400405 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL30647269 1.00 GSR (0.87) GSRNOS2NOS1NOS3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3164 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250311761-A1 METHOD FOR THE PREPARATION OF A NUTRITIONAL POWDER NESTLE SA (CH) 2025-10-09 US claimed
US-12427129-B2 Application of compound amino acids in preparation of medicament for improving sensitivity of bacteria to antibiotics SUN YAT-SEN UNIVERSITY (CN) 2025-09-30 US claimed
CN-119949497-A Formula powder containing multiple amino acids and preparation method thereof 山东美吉客生物科技有限公司 2025-05-09 CN claimed
CN-119925389-A Compound amino acid and glucose injection and preparation method thereof 湖北一半天制药有限公司 2025-05-06 CN claimed
CN-119924295-A Cell preservation solution and application thereof 深圳华大基因细胞科技有限责任公司 2025-05-06 CN claimed
EP-4539683-A1 POWDERED FOOD COMPOSITION FOR THE PREPARATION OF DRINKS FOR THE HYDRATION OF DYSPHAGIC INDIVIDUALS General Beverage S.r.l. (IT) 2025-04-23 EP claimed
CN-119837793-A Anticreep antipruritic composition and preparation method and application thereof 珠海安肽生物医药技术开发有限公司 2025-04-18 CN claimed
CN-119818484-A 14-Amino acid and glucose composition stored in double-chamber bag and preparation method thereof 湖北一半天制药有限公司 2025-04-15 CN claimed
CN-119751921-A Preparation method of amide bond crosslinked sodium hyaluronate hydrogel 浙江景嘉医疗科技有限公司 2025-04-04 CN claimed
CN-119707769-A Method for preparing caprolactam by using fermentation liquor containing lysine, lysine or lysine salt as raw materials 中国科学院长春应用化学研究所 2025-03-28 CN claimed
EP-1161956-A1 MEDICINAL COMPOSITIONS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP claimed
WO-2001051026-A2 INSTANT GRANULES AND PROCESS FOR THEIR FORMULATION DR. GERGELY & CO. (AT) 2001-07-19 WO claimed
US-5543316-A INCLUDING A SUGAR, A SERUM ALBUMIN, A CALCIUM SALT, A PHOSPHATE SALT, A SOURCE OF IRON, AMINO ACIDS, VITAMINS, GROUP I SALT AND A GROUP II SALT DIACRIN, INC. (US) 1996-08-06 US claimed
EP-0488078-B1 Diet free of phenylalanin for juveniles and adults affected with phenylketonurea MILUPA AG (DE) 1996-02-07 EP claimed
WO-1995029230-A1 CULTURE MEDIUM FOR MAINTAINING VIABILITY OF MAMMALIAN CELLS DIACRIN, INC. (US) 1995-11-02 WO claimed
CN-1091952-A Cosmetic composition UNILEVER NV (NL) 1994-09-14 CN claimed
EP-0189941-B1 ANTIBIOTIC COMPOSITIONS Bristol-Myers Squibb Company (US) 1990-09-26 EP claimed
EP-0140027-B1 AQUEOUS SOLUTION FOR COOLING COLD-ROLLED STEEL STRIP IN A CONTINUOUS ANNEALING PROCESS NIPPON STEEL CORPORATION (JP) 1989-07-05 EP claimed
EP-0189941-A2 Antibiotic compositions Bristol-Myers Squibb Company (US) 1986-08-06 EP claimed
EP-0150053-A2 Hypocaloric low osmotic aqueous preparation for infusion Oehmke, Martin, Dr. (DE) 1985-07-31 EP claimed